ArticleJapanese journal of clinical oncology2024

Real-world outcomes of ponatinib treatment in 724 patients with CML and Ph+ ALL: a post-marketing surveillance study with a special interest in arterial occlusive events in Japan.

Naoto Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.